reduce

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Source Node:
Time Stamp: April 15, 2024 1:26 PM - Modified On: April 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology New York, March 12, 2024 - (Plato Data) - Benzinga has published a new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology. The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related

Analyzing Token Sale Models

Source Node:
Time Stamp: February 20, 2024 1:29 PM - Modified On: February 20, 2024 - Published By:
Source Cluster:
Republished By Plato

Note: I mention the names of various projects below only to compare and contrast their token sale mechanisms; this should NOT be taken as an endorsement or criticism of any specific project as a whole. It's entirely possible for any given project to be total trash as a whole and yet still have an awesome token sale model. The last few months have seen an increasing amount of innovation in token sale models. Two years ago, the space was simple: there were capped sales, which sold a fixed number of

Blockpass Heralds Cutting Edge Compliance Automation – Advanced KYC Bot(TM)

Source Node:
Time Stamp: January 23, 2024 4:57 AM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Jan 18, 2024 - (ACN Newswire) - Blockpass is proud to reveal a brand-new automation advancement that will see the KYC experience for its customers improved even further with the introduction of the Advanced KYC Bot(TM). Included as standard for all Managed Service add-on clients, the handy new bot will automate the KYC process even further, reducing the time and effort required for compliance by monitoring and processing flags to KYC profiles. Also available on a standalone basis for Enterprise customers, the Advanced KYC Bot(TM) builds on the capability

1,300 E-JEEPNEY ORDER COMMITMENTS IN THE PHILIPPINES FOR TEMBO FRANCISCO MOTORS JOINT VENTURE

Source Node:
Time Stamp: January 18, 2024 1:50 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

Orders pursuant to Tembo’s previously announced joint venture with Francisco Motors Established in 1947, Francisco Motor Corporation is the original pioneering jeepney manufacturer Total addressable market to electrify 200,000 existing jeepneys estimated to be worth US$10bn+ Tembo E-LV, a subsidiary of the NASDAQ listed B Corp, VivoPower, announced today that, pursuant to its definitive joint venture agreement with Francisco Motor Corporation, it has been advised by Francisco Motors of a total of 1,300 order commitments received from several leading jeepney co-operatives in the Philippines, including Laguna, First Isabela, Progressive, and

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

The Tightrope of Regulation

Source Node:
Time Stamp: September 26, 2023 7:09 AM - Modified On: September 26, 2023 - Published By:
Source Cluster:
Republished By Plato

In a significant move at the recent G20 meeting in India, the International Monetary Fund (IMF) and the Financial Stability Board (FSB) released a joint paper outlining a framework for the global regulation of cryptocurrencies. While the proposals mostly tread familiar territory, what’s new is their conviction in crypto’s unstoppable growth and success. A flurry of optimism greeted the G20’s endorsement of the report because it advocates that countries don’t ban crypto. Hidden in its text, however, are some worrying signs. For example, on the first page, they state, “Widespread

The Convergence of MedTech and Blockchain: Transforming Healthcare

Source Node:
Time Stamp: September 14, 2023 4:39 PM - Modified On: September 14, 2023 - Published By:
Source Cluster:
Republished By Plato

The healthcare industry has witnessed a remarkable transformation driven by technological advancements in recent years. One groundbreaking convergence is the fusion of Medical Technology (MedTech) and blockchain technology. This synergy has the potential to revolutionize healthcare by enhancing data security, interoperability, and patient-centric care. Enhanced Data Security: One of the foremost challenges in healthcare is ensuring the security and privacy of patient data. Medical records contain sensitive information that must be protected from unauthorized access and cyber threats. Blockchain technology offers a robust solution to this problem. Blockchain operates on

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

FAMED PHOTOGRAPHER DAVID CHRISTOPHER LEE TO GIVE AWAY NFTS OF ICONIC PHOTOS OVER THE MONTH OF JUNE

Source Node:
Time Stamp: June 8, 2023 7:24 AM - Modified On: June 8, 2023 - Published By:
Source Cluster:
Republished By Plato

One of the NFT Giveaways Will be a Photography Portrait of Kim Kardashian Los Angeles, June 8th, 2023 - Celebrity photographer David Christopher Lee announced giveaways of several iconic photos turned NFTs over the month of June - including one of Kim Kardashian. This NFT giveaway is part of the launch of Illuminate Art, an executive talent management service for experienced artists who understand the significance of having a digital presence and virtual community. “Increasing access to art and finding innovative ways to engage with a virtual community were driving

SaaS Inclusology Releases New 2.0 Platform and Proves to Help Companies Achieve DEI (Diversity, Equity, and Inclusion) Goals in Accelerated Timeline.

Source Node:
Time Stamp: June 6, 2023 7:40 AM - Modified On: June 6, 2023 - Published By:
Source Cluster:
Republished By Plato

June 2023 - Inclusology, is a powerful all in one DEI management SaaS platform designed to help companies reduce bias in the workplace and increase employee retention. Last week, the platform released its new version after completing beta testing among 16 companies and thousands of employees across startups, nonprofits, Fortune 500 and 1000 companies etc. “We are so proud to see Inclusology’s work having a positive impact on DEI at a global level in every sized company,” says CEO Dr. Cheryl Ingram. “We’ve tested our software in a number of

The GBA Recognizes Blockchain Trailblazers

Source Node:
Time Stamp: June 4, 2023 4:13 PM - Modified On: June 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington, DC, June 4 2023 – The Government Blockchain Association (GBA) honored exceptional individuals and organizations for their groundbreaking use of blockchain technology in solving public sector challenges. The Annual Achievement Awards, presented on May 24, 2023, in Washington, DC, celebrated this year's outstanding winners. Rosemarie McClean, Chief Executive Officer, and Dino Cataldo Dell’Accio, Chief Information Officer received the award on behalf of the United Nations Joint Staff Pension Fund (UNJSPF), the Organization Award for a digital identity solution that enabled over 23,000 retirees across 180 countries, to provide their